Antitumor Effects of a New Retinoate of the Fungal Cytotoxin Illudin M in Brain Tumor Models.
Benedikt LinderMiroslava ZoldakovaZsuzsanna KörnyeiLeonhard H F KöhlerSebastian SeibtDominic MengerAndré WetzelEmília MadarászRainer SchobertDonat KögelBernhard BiersackPublished in: International journal of molecular sciences (2022)
While the fungal metabolite illudin M ( 1 ) is indiscriminately cytotoxic in cancer and non-malignant cells, its retinoate 2 showed a greater selectivity for the former, especially in a cerebral context. Illudin M killed malignant glioma cells as well as primary neurons and astrocytes at similarly low concentrations and destroyed their microtubule and glial fibrillary acidic protein (GFAP) networks. In contrast, the ester 2 was distinctly more cytotoxic in highly dedifferentiated U87 glioma cells than in neurons, which were even stimulated to enhanced growth. This was also observed in co-cultures of neurons with U87 cells where conjugate 2 eventually killed them by induction of differentiation based on the activation of nuclear receptors, which bind to retinoid-responsive elements (RARE). Hence, illudin M retinoate 2 appears to be a promising drug candidate.
Keyphrases
- induced apoptosis
- cell cycle arrest
- spinal cord
- magnetic resonance
- endoplasmic reticulum stress
- emergency department
- cell death
- subarachnoid hemorrhage
- cancer therapy
- squamous cell carcinoma
- oxidative stress
- computed tomography
- spinal cord injury
- cell proliferation
- drug delivery
- small molecule
- cell wall
- electronic health record